Delivery Order SPE2DR25D1103-SPE2DR26FE327
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,373.55 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Januvia 100 mg tablets (90-count packages). This is a firm fixed price delivery order with an ultimate completion date of November 14, 2025, and represents a non-competitive set-aside award. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 8, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a ceiling value of $4,476.36. The contract is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and was competitively awarded with no set-aside designation. This award is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 9, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a ceiling value of $2,214.76. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and represents a non-set-aside competitive award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,114.90 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication. This competitively awarded, firm fixed-price contract was executed on November 4, 2025, with an ultimate completion date of November 5, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on November 6, 2025, for supply of Januvia 100 mg tablets (90 count) valued at $2,156.12 with a firm fixed price contract type. The delivery order is non-competitive, with a completion deadline of November 7, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,339.96 for 90 tablets of Januvia 100 mg on December 11, 2025, with an ultimate completion date of December 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a child order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Januvia 50 mg tablets (90-count units) with a contract ceiling value of $4,262.40. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The ultimate completion date is set for November 14, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Januvia 100 mg tablets (90-count packages) with a ceiling value of $1,056.72. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The order is set to be completed by November 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,056.66 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract supports federal medical procurement needs, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $1,455.28. The award, issued on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the performing location for this delivery order, which falls under the...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE327Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Januvia 100 mg tablets (90-count) at a ceiling value of $2,973.35. This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency encompasses a wide range of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The SPE2DX prime contract vehicle enables AmerisourceBergen to supply comprehensive pharmaceutical support to customers including the Defense Health Agency and U.S. Coast Guard, while positioning the company competitively as the Defense Logistics Agency plans the next generation of Pharmaceutical Prime Vendor Global Program contracts with multiple anticipated regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 12/10/25 |